Academic OB/GYN Podcast Episode 31 – Delayed Cord Clamping
Guest Dr Judith Mercer of University of Rhode Island and I discuss her work investigating the impact of delayed cord clamping on term and preterm neonates.
Academic OB/GYN Podcast Episode 30 – Journals for January 2011
Drs Paul Browne and Nicholas Fogelson discuss articles from January 2011. Topics include 21 vs 24 day OCPs, Antiphospholipid Syndrome a la ACOG, Wound Complications with Lovenox, Yolk Sacs on Ultrasound, and the relation between PCOS and Dyslipidemia.
Delayed Cord Clamping Grand Rounds
I recently gave Grand Rounds on Delayed Cord Clamping. If you have an interest and a spare 50 minutes, take a look!
Academic OB/GYN Podcast Episode 29 – REI Update
Dr John Schnorr discusses new ideas in the last ten years in reproductive endocrinology. We discuss blastocyst transfer, ethics in REI, egg vitrification, ovarian reserve testing, and more!
Grand Rounds for January 4 2011
Academic OB/GYN was featured on the web’s Medical Grand Rounds for January 4 2011. Lots of good stuff worth checking out.
Academic OB/GYN Cases: The House of Twins
This is a nice photo of a diamniotic/dichorionic placenta, part of a pregnancy involving two separate embryos in the same uterus.
Note the thick intervening membrane and lack of blood vessels traveling between the two placental discs, both characteristic of a di/di placenta.
Academic OB/GYN Podcast Episode 28 – Journals for December 2010
Journals for 2010 with Nicholas Fogelson and Paul Browne. Topics include NICHD Strip Classification, Oral vs Intrauterine Progestins for Hyperplasia, Fetal Lung Maturity Outcomes Less than 39 Weeks, Congenital Toxo and more!
Academic OB/GYN Podcast Episode 28 – Journals for December 2010
The Downside of Understanding
As I look back over my 10 year career in obstetrics and gynecology, I am sometimes struck at how many things have been discovered in this time period. When I started the origin of pre-eclampsia was unknown, and now we know that it likely originates in an overabundance of a molecule called Soluble FMS-Like Tyrosine Kinase, a competitive inhibitor to natural angiogenesis in the placenta. Ten years ago the origins of cervical dysplasia were still being developed, and now we know that the majority if not the entirety of cervical dysplasia and cancer is due to an infection of Human Papillomavirus, and for all intents and purposes cervical cancer is actually a sexually transmitted disease. We have developed this idea even further, allowing us to use HPV virus detection as part of a screening program for cervical dysplasia and cancer, and even to immunize for HPV infection in young women yet to be exposed.
All of these things amaze me. But to be honest, they also make the practice of obstetrics and gynecology more difficult. We have advanced our understanding to level that is impossible to explain to patients who lack a strong background in science, forcing us to accept simplistic explanations over explanations of how it really works. Let’s use HPV as an example.
Academic OB/GYN Cases: Another Day, Another Dermoid
First blonde one for me. Gotta catch ‘em all!
